Abstract: The current teachings are directed to virus free cells lines derived from virus-contaminated starting material, such as an organism or a cell line. Methods for obtaining virus free cell lines obtained from virus-contaminated starting material are also provided. Exemplary virus free cell lines include: cell lines derived from a Spodoptera frugiperda cell line contaminated with Sf-rhabdovirus, wherein the cell lines lack Sf-rhabdovirus; and cell lines derived from a Trichoplusia ni cell line contaminated with an alphanodavirus, wherein the cell line lacks an alphanodavirus.
Type:
Grant
Filed:
November 1, 2016
Date of Patent:
October 18, 2022
Assignee:
GLYCOBAC, LLC
Inventors:
Ajay Maghodia, Christoph Geisler, Donald Jarvis
Abstract: The current teachings are directed to novel virus free cells lines derived from virus-contaminated staring material, such as an organism or a cell line. Methods for obtaining virus free cell lines obtained from virus-contaminated starting material are also provided. Exemplary virus free cell lines include: novel cell lines derived from a Spodoptera frugiperda cell line contaminated with Sf-rhabdovirus, wherein the novel cell lines lack Sf-rhabdovirus; and novel cell lines derived from a Trichoplusia ni cell line contaminated with an alphanodavirus, wherein the novel cell line lacks an alphanodavirus.
Type:
Application
Filed:
November 1, 2016
Publication date:
December 13, 2018
Applicant:
Glycobac, LLC
Inventors:
Ajay Maghodia, Christoph Geisler, Donald Jarvis